Chinese regulators announced Friday they plan to invest in the consolidation of the domestic infant milk formula industry in efforts to strengthen local competition after various foreign companies were fined for price-fixing.
According to reports, the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Finance and the China Food and Drug Administration announced late last week that it will pump funds into the industry and provide tax breaks to companies for merging. The regulators aim to create 10 infant formula competitors that own 65 percent of the market.
The plans are part of the nation’s efforts to improve the infant milk industry after six international competitors were fined $109 million for anticompetitive behavior, including price-fixing.
More than 40 foreign firms hold a presence in the Chinese market, reports say.
Full content: Forbes
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI